ScholarIQanswers from OpenAlex

Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway

PaperCitations, authors & open-access status

Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway have?

ScholarIQcitation count

Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway has 108 citations in the OpenAlex counts ScholarIQ stores.

When was Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway published?

ScholarIQyear

Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway has 2015 year in the ScholarIQ index.

What is the open-access status of Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway?

ScholarIQoa status

Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway has closed oa status in the ScholarIQ index.

What is the DOI of Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway?

ScholarIQdoi

The DOI for Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway is on the source record.

What is the PMID of Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway?

ScholarIQpmid

The PMID for Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway is on the source record.

What is the OpenAlex record for Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway?

ScholarIQopenalex

The OpenAlex for Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial